Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis (Q34549268)

3 August 2017

title

Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis (English)

1 reference

3 August 2017

0 references

hepatocellular carcinoma

1 reference

Toshiya Kamiyama

1 reference

3 August 2017

Hideki Yokoo

1 reference

3 August 2017

Jun-Ichi Furukawa

1 reference

3 August 2017

Masaki Kurogochi

1 reference

3 August 2017

Tomoaki Togashi

1 reference

3 August 2017

Nobuaki Miura

1 reference

3 August 2017

Kazuaki Nakanishi

1 reference

3 August 2017

Hirofumi Kamachi

1 reference

3 August 2017

Tatsuhiko Kakisaka

1 reference

3 August 2017

Yosuke Tsuruga

1 reference

3 August 2017

Masato Fujiyoshi

1 reference

3 August 2017

Akinobu Taketomi

1 reference

3 August 2017

Shin-Ichiro Nishimura

1 reference

3 August 2017

Satoru Todo

1 reference

3 August 2017

language of work or name

English

0 references

publication date

26 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

2314-2325

1 reference

Hepatocellular carcinoma pathogenesis: from genes to environment

3 August 2017

cites work

1 reference

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

21 January 2018

1 reference

Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization

21 January 2018

1 reference

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma

21 January 2018

1 reference

N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing

21 January 2018

1 reference

A serum glycomics approach to breast cancer biomarkers

21 January 2018

1 reference

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer

21 January 2018

1 reference

BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics

21 January 2018

1 reference

High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry.

21 January 2018

1 reference

Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion

21 January 2018

1 reference

A new look at the statistical model identification

21 January 2018

1 reference

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

21 January 2018

1 reference

Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels

21 January 2018

1 reference

Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell

21 January 2018

1 reference

Occurrence of alpha‐fetoprotein in acute viral hepatitis

21 January 2018

1 reference

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma

21 January 2018

1 reference

N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma

21 January 2018

1 reference

Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data

21 January 2018

1 reference

Human serum N-glycan profiles are age and sex dependent

21 January 2018

1 reference

Prognostic impact of anatomic resection for hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey

1 reference

7 January 2021

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

7 January 2021

Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma

1 reference

7 January 2021

Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma

1 reference

7 January 2021

The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin

1 reference

7 January 2021

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation

1 reference

7 January 2021

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation

1 reference

7 January 2021

Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma

1 reference

7 January 2021

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

7 January 2021

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis

1 reference

7 January 2021

Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants

1 reference

7 January 2021

Alpha(1)-fetoprotein in chronic liver disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26262

1 reference

3 August 2017

1 reference